Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
FEBS Letters|June 25, 1984
Specific labelling by [125I]helodermin of high-affinity VIP receptors in rat liver membranesP Robberecht, M Waelbroeck, P de Neef, et al.
Peptides|March 1, 1984
Specific decrease of secretin/VIP-stimulated adenylate cyclase in the heart from the Lyon strain of hypertensive ratsP Robberecht, L Gillet, P Chatelain, et al.
Endocrinology|November 1, 1985
Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranesP Robberecht, D H Coy, M Waelbroeck, et al.
Peptides|January 1, 1997
The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclassP Gourlet, P Vertongen, A Vandermeers, et al.
Biochimica Et Biophysica Acta|July 22, 1991
The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranesP Gourlet, P De Neef, M C Woussen-Colle, et al.
Molecular Pharmacology|August 1, 1992
Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21P Robberecht, P Gourlet, P De Neef, et al.
Pflugers Archiv : European Journal of Physiology|April 1, 1983
Topographical distribution of the secretin- and VIP-stimulated adenylate cyclase system in the heart of five animal speciesP Chatelain, P Robberecht, M Waelbroeck, et al.
European Journal of Biochemistry|July 1, 1992
Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonistP Robberecht, P Gourlet, P De Neef, et al.
Molecular and Cellular Endocrinology|January 1, 1995
Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide stimulate two signaling pathways in CHO cells stably transfected with the selective type I PACAP receptorC Delporte, P Poloczek, P de Neef, et al.
Gastroenterology|September 1, 1992
Stimulation of rat pancreatic tumoral AR4-2J cell proliferation by pituitary adenylate cyclase-activating peptideL Buscail, C Cambillau, C Seva, et al.
Pageof 12